Heljo Krall

Suggest Changes
Learn More
Six double-blind studies were designed to assess the efficacy, tolerance, and safety of the angiotensin-converting enzyme inhibitor ramipril in patients with mild-to-moderate essential hypertension.(More)
  • 1